Pharmaceuticals news FT.com

Novo Nordisk shares jump up on latest weight-loss drug trial results

People treated with amycretin lost up to 22% of their body weight after 36 weeks

Feb 9, 2025 - 22:26
 0
Novo Nordisk shares jump up on latest weight-loss drug trial results
People treated with amycretin lost up to 22% of their body weight after 36 weeks
Read More

Tags:

Previous Article

Obesity drug sales surge at Novo Nordisk

Next Article

Trump steers the world toward a tax war

Related Posts

Rapid trials prompt deals rush for Chinese ‘super me-too’ drugs

Rapid trials prompt deals rush for Chinese ‘super me-to...

Feb 9, 2025  0

The big haul

The big haul

Feb 9, 2025  0

Activist fund takes aim at one of Japan’s biggest pharma groups

Activist fund takes aim at one of Japan’s biggest pharm...

Feb 12, 2025  0